-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Sinochem News.
com News on June 28, Guoen shares announced that the company has signed a "share transfer agreement" with Hainan Dongbao Industrial Co.
, Ltd.
to acquire 60 million shares of Dongbao Biotechnology held by it at a price of 6 Yuan, the total transaction amount is 360 million yuan
.
After the completion of the transfer, Guoen shares will hold 126 million shares of Dongbao Bio, accounting for 21.
14% of Dongbao Bio's total share capital, and become the controlling shareholder of Dongbao Bio
.
It is understood that Dongbao Bio was established in 1997.
The company's main products include gelatin, collagen, compound emulsifiers, dicalcium phosphate, bio-organic fertilizer (still under construction) and so on
.
Among them, the main products of gelatin revenue accounted for 90%, as the main raw material of medicinal hollow capsules with Guoen shares medicinal hollow capsules business have a synergistic effect
Guoen shares stated that the company will make full use of its high-quality industrial resources, play a synergistic effect with the company's business, enhance the company's competitive advantage in the gelatin industry chain business, and enhance the company's core competitiveness, risk resistance and sustainable development capabilities